cabozantinib,avelumab
pfizer,merck
['cabozantinib', 'urothelial', 'avelumab', 'main-cav']
main-cav: piii randomized trial of maintenance cabozantinib &amp; avelumab vs avelumab after first-line platinum-based chemotherapy in pts with metastatic #urothelialcancer. presentation by . #asco23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology